BRIEF published on 03/31/2026 at 07:35, 5 days 17 hours ago Dermapharm Holding SE prévoit des résultats financiers mitigés en 2025 Baisse Des Revenus Augmentation De L'EBITDA Croissance Des Produits Pharmaceutiques De Marque Stabilité Des Produits De Santé Dépôt D'importation Parallèle
BRIEF published on 03/31/2026 at 07:35, 5 days 17 hours ago Dermapharm Holding SE sees mixed financial outcomes in 2025 Revenue Decline EBITDA Increase Branded Pharmaceuticals Growth Healthcare Products Stability Parallel Import Drop
PRESS RELEASE published on 03/31/2026 at 07:30, 5 days 17 hours ago Dermapharm Holding SE reports dip in revenue, rise in adjusted consolidated EBITDA and margin Dermapharm Holding SE reports dip in revenue but rise in adjusted consolidated EBITDA and margin for the 2025 financial year, with expectations of further growth in 2026 Adjusted EBITDA Dermapharm Holding SE Revenue Dip Financial Year 2025 Margin Rise
BRIEF published on 03/26/2026 at 20:53, 10 days 3 hours ago Dermapharm procède à un rachat d'actions face à un fort intérêt Rachat D'actions Marché Boursier Gestion Financière Dermapharm Actions Du Trésor
BRIEF published on 03/26/2026 at 20:53, 10 days 3 hours ago Dermapharm Executes Share Buyback Amid Strong Interest Share Buyback Financial Management Treasury Shares Stock Market Dermapharm
PRESS RELEASE published on 03/26/2026 at 20:48, 10 days 3 hours ago Dermapharm Holding SE repurchases 4,299,190 shares under its public share buyback offer Dermapharm Holding SE repurchases 4,299,190 shares under its public share buyback offer. Company's buyback program exceeded maximum shares tendered. Offer price to be available by 2 April 2026 Share Buyback Treasury Shares Public Offer Dermapharm Holding SE Stock Repurchase
BRIEF published on 03/10/2026 at 09:16, 26 days 15 hours ago Dermapharm Holding SE Announces Share Buyback Offer Share Buyback Dermapharm Holding SE Capital Measures 4,300,000 Shares EUR 42.00 Per Share
BRIEF published on 03/10/2026 at 09:16, 26 days 15 hours ago Dermapharm Holding SE annonce une offre de rachat d'actions Rachat D'actions Dermapharm Holding SE Mesures De Capital 4 300 000 Actions 42,00 EUR Par Action
PRESS RELEASE published on 03/10/2026 at 09:11, 26 days 15 hours ago EQS-Adhoc: Dermapharm Holding SE resolves public share buyback offer for up to 4,300,000 shares Dermapharm Holding SE resolves public share buyback offer for up to 4,300,000 shares, at EUR 42.00 per share. Details at https://ir.dermapharm.de Investor Relations Share Buyback Offer Public Offer Dermapharm Holding SE EUR 42.00 Per Share
BRIEF published on 03/10/2026 at 07:35, 26 days 17 hours ago Dermapharm Reports Revenue Decline, EBITDA Improvement in 2025 Revenue Decline EBITDA Growth Healthcare Products Dermapharm 2025 Earnings
Published on 04/02/2026 at 22:00, 3 days 2 hours ago Star Copper Announces Closing of Charity Flow-Through Unit Private Placement
Published on 04/02/2026 at 18:32, 3 days 6 hours ago Datavault AI CEO Nathaniel Bradley to Present DataValue(R), DataScore(R), and Information Data Exchange(R) Technologies at XRP Tokyo 2026
Published on 04/02/2026 at 15:00, 3 days 9 hours ago Jaguar Health Family Company Napo Pharmaceuticals Co-Sponsoring Pediatric Gastroenterology Conference: Elite Ped-GI Congress
Published on 04/02/2026 at 14:40, 3 days 10 hours ago Northfield Capital Completes Acquisition Of Additional Interest In Juno Corp. And Announces Issuance Of Class B Multiple Voting Shares
Published on 04/02/2026 at 14:30, 3 days 10 hours ago Worksport Announces COR(TM) Portable Energy System Is Now Fully Certified, Including Key UL and CSA Approvals, for North American Retail and Commercial Distribution
Published on 04/04/2026 at 10:07, 1 day 14 hours ago Heidelberg Pharma to Present Data from its ADC Technology Platform at AACR Annual Meeting 2026
Published on 04/04/2026 at 02:05, 1 day 22 hours ago Blokees made its debut at 2026 Thailand Toy Expo, exhibiting multiple products
Published on 04/03/2026 at 18:00, 2 days 6 hours ago IEVA GROUP: IMPLEMENTATION OF A LIQUIDITY AGREEMENT WITH CREDIT INDUSTRIEL ET COMMERCIAL
Published on 04/03/2026 at 18:00, 2 days 6 hours ago IEVA GROUP: MISE EN OEUVRE D’UN CONTRAT DE LIQUIDITE AVEC LE CREDIT INDUSTRIEL ET COMMERCIAL
Published on 04/03/2026 at 17:45, 2 days 7 hours ago Atbash Launches on Chromia to Enable Verifiable, User-Controlled AI Systems
Published on 04/03/2026 at 18:46, 2 days 6 hours ago Disclosure of Share Capital and Voting Rights as of March 31, 2026
Published on 04/03/2026 at 18:46, 2 days 6 hours ago Déclaration du nombre d’actions et droits de vote au 31 mars 2026
Published on 04/03/2026 at 18:01, 2 days 6 hours ago ALTAREIT : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 04/03/2026 at 18:00, 2 days 6 hours ago ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 04/03/2026 at 18:00, 2 days 6 hours ago LANSON-BCC : Déclaration du nombre total des droits de vote et du nombre d’actions au 31 mars 2026
